Coban 60 Premix 132.2 g Drug Premix is a Health Canada–registered veterinary drug (DIN 00423130) held by Elanco Division Eli Lilly Canada Inc, containing Monensin. Health Canada lists its status as Cancelled Post Market (status date 24 Sep 1999). Nexara Health has matched 1 registration of Monensin across 1 other regulated market.
Health Canada registration
| DIN | 00423130 |
|---|---|
| Brand name | Coban 60 Premix |
| Active ingredient | Monensin |
| Strength | 132.2 g |
| Dosage form | Drug Premix |
| Route | Oral |
| Company | Elanco Division Eli Lilly Canada Inc |
| Status | Cancelled Post Market — 24 Sep 1999 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Monensin registered in other markets
1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Kexxtone | Elanco GmbH | 32,4 g | intraruminalt indlæg | Central | Laegemiddelstyrelsen |
See every manufacturer of Monensin worldwide →
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02231172 | Coban Premix | Elanco Canada Limited | 200 g | Drug Premix |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Coban 60 Premix (DIN 00423130) marketed in Canada?
No. Health Canada lists DIN 00423130 as Cancelled Post Market as of 24 Sep 1999.
Who holds the Canadian licence for this product?
Elanco Division Eli Lilly Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Monensin registered outside Canada?
Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00423130, status date 1999-09-24; national medicine registries: Laegemiddelstyrelsen. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00423130, status date 1999-09-24; national medicine registries: Laegemiddelstyrelsen.
Health Canada Drug Product Database (DPD), DIN 00423130, status date 1999-09-24; national medicine registries: Laegemiddelstyrelsen. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.